REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 4.00 (8.00%)
Open: 52.00
High: 52.00
Low: 52.00
Prev. Close: 52.00
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Review of Ogden Discount Rate

2 Mar 2017 14:30

RNS Number : 3824Y
Frenkel Topping Group PLC
02 March 2017
 

Frenkel Topping Group plc

("Frenkel Topping" or the "Company")

Review of Ogden Discount Rate

 

Frenkel Topping (AIM: FEN), a specialist independent financial advisor and asset manager focussed on asset protection for vulnerable clients, provides the following update in relation to the announced change to the discount rate from 2.5% to -0.75% and how it affects the business.

Discount Rate from 2.5% to -0.75%

On the morning of 27 February 2017, the Lord Chancellor ruled that the Ogden discount rate which is used to calculate the damages awarded in clinical negligence and personal injury claims be set at -0.75% rather that the current 2.5%, effective from 20 March 17.

This announcement has dramatically changed how compensation damages are calculated. The last change to the discount rate was in 2001. 

Impact on Damages Award

We are revising the Assets Under Management (AUM) growth assumptions in our business as follows;

Year

Previous Organic Growth Assumption

Revised Organic Growth Assumption

2017

£75m

£100m

2018

£100m

£180m

2019

£100m

£180m

 

Frenkel Topping has calculated that the size of court damages is likely to grow significantly. Using pipeline cases, Frenkel Topping has calculated the following increases as examples:

Quantum @ 2.5% discount rate

Quantum @-0.75% discount rate

Quantum uplift

Claimant Age

Life Expectation

@ 2.5%

@ -0.75%

44

7 year reduction

£ 5,199,736.00

£ 7,640,843.79

47%

57

Normal

£ 3,856,463.00

£ 6,122,055.90

59%

11

Normal

£ 3,619,529.00

£ 6,892,115.39

90%

36

Normal

£ 6,637,936.00

£ 12,596,746.00

90%

13

24 year reduction

£ 9,956,514.00

£ 18,505,359.33

86%

36

Normal

£ 1,784,602.00

£ 3,382,087.37

90%

58

5 year reduction

£ 3,672,383.00

£ 5,545,186.61

51%

8

18 year reduction

£ 5,787,612.00

£ 14,031,550.15

142%

 

Having conducted an analysis over the last 6 months of large loss cases that we have been involved in, the average increase in overall quantum, had the discount rate been -0.75%, is c.80%.

Impact on Periodical Payment Orders (PPO)

A client's decision to receive a PPO instead of a lump sum has been impacted by this change to the discount rate. Claimants who have historically taken a PPO will now favour a lump sum because the peace of mind and diminished need for investment risk, previously only available with a PPO, has in effect been provided within the lump sum. The claimant now not only has a lump sum of damages significantly increased to meet their lifetime needs, but has the added advantage of the flexibility a lump sum award offers.

Clients' desire to take investment risk

With a historic 2.5% discount rate, clients need to take investment risk in order to generate this level of return, net of fees. With a revised -0.75% discount rate, clients' risk appetite is reduced. This is aligned to the ethos of Frenkel Topping's Safety First Portfolios.

Impact to Frenkel Topping

The rate of growth of AUM is expected to accelerate exponentially as a result of clients in receipt of large damage awards.

With larger awards, lower periodical payment orders and a core investment strategy geared towards a lower risk appetite, the market place the company operates within and thus the AUM and profitability of the Company is likely to grow, as shown in the tables below:

Organic AUM growth per annum £'m

Operating profit £'m

Closing AUM £'m

2017

2018

2019

2017

2018

2019

2017

2018

2019

75

100

100

3.40

4.30

5.50

820

920

1,020

100

100

100

3.53

4.55

5.75

845

945

1,045

100

150

150

3.53

4.80

6.50

845

995

1,145

100

200

200

3.53

5.05

7.25

845

1,045

1,245

 

Given our expertise in this market place we recognise that there will be a hiatus in cases settling as court dates will be postponed as lawyers recalculate schedules based on the new discount rate. Therefore the uplift in AUM is expected to flow during H2 2017.

Jason Granite, Executive Chairman said "The changes announced will dramatically increase damages paid to our future clients and as a result, accelerate growth of AUM at Frenkel Topping. The Board is excited at the additional growth prospects this represents.

Higher damages awards will also result in an increase quality of life for those with life changing events outside of their control. As we continue to build higher levels of AUM and drive profitability within the business, we will remain totally focused on supporting clients post settlement for the remainder of their life, delivering excellent customer service and maintaining our 99% client retention rate."

 

For further information:

 

Frenkel Topping Group plc

Jason Granite, Executive Chairman

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

Julie Dean, Chief Financial Officer

finnCap Ltd

Tel: 020 7220 0500

Adrian Hargrave / James Thompson / Alex Price (Corporate Finance)

Tony Quirke (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

 

About Frenkel Topping: www.frenkeltopping.co.uk

Frenkel Topping provides specialist independent financial advice focussed on asset protection for clients. The specialist independent financial adviser has a market leading position providing advice and fund management services for personal injury trusts and clinical negligence awards and is well placed to provide services to a wider customer base.

The Company provides a range of wealth management services including bespoke investment portfolios, financial and tax planning. It is focused on increasing its assets under management by growing the number of fee earners who are qualified to provide benefits protection for a variety of needs as the Company adds to its personal injury and clinical negligence specialism.

It has a national presence with offices in Manchester, Birmingham, Bristol, Cardiff, London and Leeds and has relationships and infrastructure in place to further grow its reach and target markets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUAGWUPMGCP
Date   Source Headline
8th May 20247:00 amRNSAnnual Report Posting, Notice of AGM & Dividend
1st May 202410:25 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
22nd Apr 20247:01 amRNSAcquisition
22nd Apr 20247:00 amRNSFinal Results
12th Mar 20247:00 amRNSNotice of Results
20th Feb 20247:00 amRNSDirectorate Change
24th Jan 20247:00 amRNSTrading Update & New Debt Facility
22nd Dec 20238:00 amRNSHolding(s) in Company
13th Nov 20237:00 amRNSPartnership Programme Grows with New Joint Venture
8th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20238:30 amRNSHolding(s) in Company
3rd Oct 20237:00 amRNSThe Shares and AJ Bell Media investor event
3rd Oct 20237:00 amRNSAppointment of Strategy & Implementation Director
29th Sep 20237:00 amRNSInterim Results
31st Aug 202310:08 amRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSDirector Share Purchase
22nd Aug 20237:00 amRNSTrading Update
31st Jul 20237:00 amRNSFEN Announces Joint Venture with Lime Solicitors
21st Jul 20233:20 pmRNSIssue of consideration shares
6th Jul 20237:00 amRNSFEN announces New Major Trauma Centre
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
14th Jun 202312:20 pmRNSResult of AGM
5th Jun 20237:00 amRNSFEN announces New Major Trauma Centre
15th May 20234:15 pmRNSAnnual Report Posting, Notice of AGM & Dividend
24th Apr 20237:00 amRNSFinal Results
22nd Mar 20234:00 pmRNSHolding(s) in Company
15th Mar 202311:47 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSInvestor Presentation
13th Feb 20237:00 amRNSFrenkel Topping Partnership Programme Grows
7th Feb 20237:00 amRNSTrading Update and Notice of Results
10th Nov 20222:50 pmRNSInterim Dividend Timetable
3rd Nov 20227:00 amRNSFEN to present at AJ Bell investor webinar
24th Oct 20222:30 pmRNSDirector/PDMR Shareholding and Holdings in Company
24th Oct 202212:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSCompletion of Two Acquisitions
31st Aug 20222:15 pmRNSNotice of Results
3rd Aug 202210:17 amRNSHolding(s) in Company
3rd Aug 202210:15 amRNSHolding(s) in Company
29th Jul 202212:15 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
12th Jul 202210:50 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSResults of Placing
5th Jul 20222:45 pmRNSProposed Placing to raise approximately £10m
22nd Jun 202211:40 amRNSResult of AGM
16th May 20228:25 amRNSAnnual Report Posting, Notice of AGM & Dividend
4th May 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.